Screener
DaVita DVA Redeemable NCI
Redeemable NCI at other companies
Other financials
Where this comes from
Reported directly by DaVita in its filing.
Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.
The source filing: DaVita’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 5:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000927066-26-000062
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Deferred income taxes | 818,918 | 756,869 |
| Total liabilities | 16,451,199 | 16,321,665 |
| Commitments and contingencies | ||
| Noncontrolling interests subject to put provisions | 1,524,505 | 1,532,166 |
| Equity: | ||
| Preferred stock ($0.001 par value, 5,000 shares authorized; none issued) | — | — |
| Common stock ($0.001 par value, 450,000 shares authorized; 69,190 shares issued and 66,185 outstanding at March 31, 2026, respectively, and 68,549 shares issued and outstanding at December 31, 2025) | 69 | 69 |
| Additional paid-in capital | — | — |
Item 1. Condensed Consolidated Financial Statements:
FAQ
- What is DaVita's redeemable NCI?
- DaVita (DVA) reported redeemable NCI of $1.52B in Q1 2026.
- How has DaVita's redeemable NCI changed year-over-year?
- DaVita's redeemable NCI decreased by 8.5% year-over-year, from $1.67B to $1.52B.
- What is the long-term trend for DaVita's redeemable NCI?
- Over 5 years (2020 to 2025), DaVita's redeemable NCI has grown at a 2.9% compound annual growth rate (CAGR), from $1.33B to $1.53B.
- What does redeemable NCI mean?
- Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.
Ask your AI about DaVita's redeemable nci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude